Clinical Trial: Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812701) titled 'Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis' on Aug. 10.

Brief Summary: This is a randomized, double-blind, comparative trial evaluating the efficacy on pain intensity between topical Clobetasol Propionate 0.05% and placebo in patients with symptomatic hand osteoarthritis.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Hand Osteoarthritis

Intervention: DRUG: Propionate de Clobetasol ( 0.05 %)

From D0-D28 a dose of cream (Clobetasol Propionate 0.05%) will be applied twice a day for 2 weeks then once a day for 2 weeks on painful joints with the maximum dose being the equivalent of a ...